Literature DB >> 21482548

Expected value and prediction error abnormalities in depression and schizophrenia.

Victoria B Gradin1, Poornima Kumar, Gordon Waiter, Trevor Ahearn, Catriona Stickle, Marteen Milders, Ian Reid, Jeremy Hall, J Douglas Steele.   

Abstract

The dopamine system has been linked to anhedonia in depression and both the positive and negative symptoms of schizophrenia, but it remains unclear how dopamine dysfunction could mechanistically relate to observed symptoms. There is considerable evidence that phasic dopamine signals encode prediction error (differences between expected and actual outcomes), with reinforcement learning theories being based on prediction error-mediated learning of associations. It has been hypothesized that abnormal encoding of neural prediction error signals could underlie anhedonia in depression and negative symptoms in schizophrenia by disrupting learning and blunting the salience of rewarding events, and contribute to psychotic symptoms by promoting aberrant perceptions and the formation of delusions. To test this, we used model based functional magnetic resonance imaging and an instrumental reward-learning task to investigate the neural correlates of prediction errors and expected-reward values in patients with depression (n=15), patients with schizophrenia (n=14) and healthy controls (n=17). Both patient groups exhibited abnormalities in neural prediction errors, but the spatial pattern of abnormality differed, with the degree of abnormality correlating with syndrome severity. Specifically, reduced prediction errors in the striatum and midbrain were found in depression, with the extent of signal reduction in the bilateral caudate, nucleus accumbens and midbrain correlating with increased anhedonia severity. In schizophrenia, reduced prediction error signals were observed in the caudate, thalamus, insula and amygdala-hippocampal complex, with a trend for reduced prediction errors in the midbrain, and the degree of blunting in the encoding of prediction errors in the insula, amygdala-hippocampal complex and midbrain correlating with increased severity of psychotic symptoms. Schizophrenia was also associated with disruption in the encoding of expected-reward values in the bilateral amygdala-hippocampal complex and parahippocampal gyrus, with the degree of disruption correlating with psychotic symptom severity. Neural signal abnormalities did not correlate with negative symptom severity in schizophrenia. These findings support the suggestion that a disruption in the encoding of prediction error signals contributes to anhedonia symptoms in depression. In schizophrenia, the findings support the postulate of an abnormality in error-dependent updating of inferences and beliefs driving psychotic symptoms. Phasic dopamine abnormalities in depression and schizophrenia are suggested by our observation of prediction error abnormalities in dopamine-rich brain areas, given the evidence for dopamine encoding prediction errors. The findings are consistent with proposals that psychiatric syndromes reflect different disorders of neural valuation and incentive salience formation, which helps bridge the gap between biological and phenomenological levels of understanding.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21482548     DOI: 10.1093/brain/awr059

Source DB:  PubMed          Journal:  Brain        ISSN: 0006-8950            Impact factor:   13.501


  150 in total

1.  Effort-based decision-making in major depressive disorder: a translational model of motivational anhedonia.

Authors:  Michael T Treadway; Nicholas A Bossaller; Richard C Shelton; David H Zald
Journal:  J Abnorm Psychol       Date:  2012-07-09

Review 2.  Motivational Deficits in Schizophrenia and the Representation of Expected Value.

Authors:  James A Waltz; James M Gold
Journal:  Curr Top Behav Neurosci       Date:  2016

Review 3.  Reinforcement learning models and their neural correlates: An activation likelihood estimation meta-analysis.

Authors:  Henry W Chase; Poornima Kumar; Simon B Eickhoff; Alexandre Y Dombrovski
Journal:  Cogn Affect Behav Neurosci       Date:  2015-06       Impact factor: 3.282

4.  Amotivation in schizophrenia: integrated assessment with behavioral, clinical, and imaging measures.

Authors:  Daniel H Wolf; Theodore D Satterthwaite; Jacob J Kantrowitz; Natalie Katchmar; Lillie Vandekar; Mark A Elliott; Kosha Ruparel
Journal:  Schizophr Bull       Date:  2014-03-22       Impact factor: 9.306

Review 5.  Identifying predictors, moderators, and mediators of antidepressant response in major depressive disorder: neuroimaging approaches.

Authors:  Mary L Phillips; Henry W Chase; Yvette I Sheline; Amit Etkin; Jorge R C Almeida; Thilo Deckersbach; Madhukar H Trivedi
Journal:  Am J Psychiatry       Date:  2015-02-01       Impact factor: 18.112

6.  Impaired Activation in Cognitive Control Regions Predicts Reversal Learning in Schizophrenia.

Authors:  Adam J Culbreth; James M Gold; Roshan Cools; Deanna M Barch
Journal:  Schizophr Bull       Date:  2015-06-06       Impact factor: 9.306

7.  From laboratory to life: associating brain reward processing with real-life motivated behaviour and symptoms of depression in non-help-seeking young adults.

Authors:  Jindra M Bakker; Liesbet Goossens; Poornima Kumar; Iris M J Lange; Stijn Michielse; Koen Schruers; Jojanneke A Bastiaansen; Ritsaert Lieverse; Machteld Marcelis; Thérèse van Amelsvoort; Jim van Os; Inez Myin-Germeys; Diego A Pizzagalli; Marieke Wichers
Journal:  Psychol Med       Date:  2018-11-29       Impact factor: 7.723

8.  Reduced dopamine transporter expression in the amygdala of subjects diagnosed with schizophrenia.

Authors:  Matej Markota; Jessica Sin; Harry Pantazopoulos; Rebecca Jonilionis; Sabina Berretta
Journal:  Schizophr Bull       Date:  2014-06-16       Impact factor: 9.306

Review 9.  Assessing anhedonia in depression: Potentials and pitfalls.

Authors:  Sakina J Rizvi; Diego A Pizzagalli; Beth A Sproule; Sidney H Kennedy
Journal:  Neurosci Biobehav Rev       Date:  2016-03-06       Impact factor: 8.989

Review 10.  The motivation and pleasure dimension of negative symptoms: neural substrates and behavioral outputs.

Authors:  Ann M Kring; Deanna M Barch
Journal:  Eur Neuropsychopharmacol       Date:  2014-01-22       Impact factor: 4.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.